Official Title
Descriptive and Evaluation Study of the Use of Pulmonary Ultrasound in the Initial Management of Pregnant Women in the Context of COVID-19
Brief Summary

Cohort prospective study. Objectives : Primary objective: To describe the lung ultrasound lesions in pregnant women in case of suspected or confirmed COVID-19 Secondary objectives: - To compare the lung ultrasound lesions with chest Computed Tomography -scanner (CT-Scan) lesions - To evaluate the performances of the lung ultrasound to diagnose COVID-19 in pregnant women - To evaluate predictive value of different lung ultrasound lesions for intensive care unit admission of pregnant women with suspected or confirmed COVID-19 - To describe the pregnancy issues of the study population Course of the study: - Inclusion of pregnant suspected of having COVID-19 and cared following the service protocol - Performing of lung ultrasound at bedside in labor ward or in COVID unit Primary outcome: Lung ultrasound lesions (and corresponding score) at the moment of the initial management of pregnant women suspected or confirmed with COVID-19 (having a nasopharyngeal Reverse Transcription Polymerase Chain Reaction (RT-PCR) SARS-CoV-2 and a chest CT-scan)

Terminated
Pregnant Women Suspected of COVID-19

Device: Performing of lung ultrasound

Performing of lung ultrasound at bedside in labor ward or in COVID unit

Eligibility Criteria

Inclusion Criteria:

- Age greater than or equal to 18 years

- Gestational age greater than or equal to 22 weeks of gestation

- Pregnant women suspected of COVID-19 :

- already having a nasopharyngeal RT-PCR for the SARS-CoV-2

- AND having a chest CT-scan or waiting for this exam

- Women giving a writing consent to participate

Exclusion Criteria:

- Women giving an opposition to participate

- Women not enough fluent in French to benefit from clear and intelligible information

Eligibility Gender
Female
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Assistance Publique Hôpitaux de Marseille
Marseille, France

Jean-Olivier ARNAUD, Director, Study Director
Assistance Publique Hôpitaux de Marseille

Assistance Publique Hopitaux De Marseille
NCT Number
MeSH Terms
COVID-19